Expertise in
5
conditions

Dr. Michael P. Link

Pediatric Hematology Oncology
Stanford Medicine - Children's Health
Lpch Medical Group Div Of Lucile
725 Welch Rd, 
Palo Alto, CA 

Expertise in
5
conditions
Stanford Medicine - Children's Health
Lpch Medical Group Div Of Lucile
725 Welch Rd, 
Palo Alto, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Link is a Pediatric Hematologist Oncology provider in Palo Alto, California. Dr. Link is highly rated in 5 conditions, according to our data. His top areas of expertise are Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Classical Hodgkin Lymphoma, and Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).

His clinical research consists of co-authoring 35 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

LPCH MEDICAL GROUP DIV OF LUCILE
725 Welch Rd, Palo Alto, CA 94304
Call: 650-498-7200

Additional Areas of Focus

Dr. Link has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Drug, Radiation, Other
Study Drugs: Bendamustine, Etoposide, Doxorubicin, Bleomycin, Vincristine, Vinblastine, Prednisone, Filgrastim, Brentuximab, Cyclophosphamide, Dacarbazine
Study Phase: Phase 2
Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favorable Risk Pediatric Hodgkin Lymphoma
Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favorable Risk Pediatric Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2025
Intervention Type: Drug, Radiation
Study Drugs: Doxorubicin, Vinblastine, Mechlorethamine, Vincristine, Bleomycin, Etoposide, Prednisone
Study Phase: Phase 2
Adcetris (Brentuximab Vedotin), Substituting Vincristine in the OEPA/COPDac Regimen [Treatment Group 3 (TG3) of Euro-Net C1] With Involved Node Radiation Therapy for High Risk Pediatric Hodgkin Lymphoma (HL)
Adcetris (Brentuximab Vedotin), Substituting Vincristine in the OEPA/COPDac Regimen [Treatment Group 3 (TG3) of Euro-Net C1] With Involved Node Radiation Therapy for High Risk Pediatric Hodgkin Lymphoma (HL)
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2025
Intervention Type: Radiation, Drug, Other
Study Drugs: Brentuximab, Etoposide, Prednisone, Doxorubicin, Cyclophosphamide, Dacarbazine, Filgrastim
Study Phase: Phase 2
School Response to Families Who Have Children With Cancer
School Response to Families Who Have Children With Cancer
Enrollment Status: Withdrawn
Publish Date: June 26, 2017
Intervention Type: Procedure
View 3 Less Clinical Trials

35 Total Publications

Pediatric relapsed/refractory ALK+ anaplastic large cell lymphoma treatment and outcomes in the targeted drug era.
Pediatric relapsed/refractory ALK+ anaplastic large cell lymphoma treatment and outcomes in the targeted drug era.
Journal: Blood advances
Published: September 06, 2024
View All 35 Publications
Similar Doctors
Expertise in
23
conditions
Dr. Bertil E. Glader
Pediatric Hematology Oncology
Expertise in
23
conditions
Dr. Bertil E. Glader
Pediatric Hematology Oncology
725 Welch Rd, 
Palo Alto, CA 
 (0.1 miles away)
650-497-8000
Languages Spoken:
English
See accepted insurances

Bertil Glader is a Pediatric Hematologist Oncology provider in Palo Alto, California. Dr. Glader is highly rated in 23 conditions, according to our data. His top areas of expertise are Aase Syndrome, Pyruvate Kinase Deficiency, Pure Red Cell Aplasia, Anemia, and Splenectomy.

Expertise in
14
conditions
Dr. Elliott P. Vichinsky
Pediatric Hematology Oncology
Expertise in
14
conditions
Dr. Elliott P. Vichinsky
Pediatric Hematology Oncology
747 52nd St, 
Oakland, CA 
 (28.1 miles away)
510-428-3651
Languages Spoken:
English
See accepted insurances

Elliott Vichinsky is a Pediatric Hematologist Oncology provider in Oakland, California. Dr. Vichinsky is highly rated in 14 conditions, according to our data. His top areas of expertise are Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.

Expertise in
12
conditions
Dr. Ashutosh P. Lal
Pediatric Hematology Oncology
Expertise in
12
conditions
Dr. Ashutosh P. Lal
Pediatric Hematology Oncology

University Of California San Francisco

505 Parnassus Ave, 
San Francisco, CA 
 (27.4 miles away)
415-476-1000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ashutosh Lal is a Pediatric Hematologist Oncology provider in San Francisco, California. Dr. Lal is highly rated in 12 conditions, according to our data. His top areas of expertise are Thalassemia, Beta Thalassemia, Congenital Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.

VIEW MORE Pediatric Hematologist Oncologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Link's expertise for a condition
ConditionClose
    • Distinguished
    • Hodgkin Lymphoma
      Dr. Link is
      Distinguished
      . Learn about Hodgkin Lymphoma.
      See more Hodgkin Lymphoma experts
    • Advanced
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Link is
      Advanced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Classical Hodgkin Lymphoma
      Dr. Link is
      Advanced
      . Learn about Classical Hodgkin Lymphoma.
      See more Classical Hodgkin Lymphoma experts
    • Febrile Neutropenia
      Dr. Link is
      Advanced
      . Learn about Febrile Neutropenia.
      See more Febrile Neutropenia experts
    • Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
      Dr. Link is
      Advanced
      . Learn about Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
      See more Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) experts
    • Experienced
    • Childhood Acute Myeloid Leukemia
      Dr. Link is
      Experienced
      . Learn about Childhood Acute Myeloid Leukemia.
      See more Childhood Acute Myeloid Leukemia experts
    • Hemophagocytic Lymphohistiocytosis
      Dr. Link is
      Experienced
      . Learn about Hemophagocytic Lymphohistiocytosis.
      See more Hemophagocytic Lymphohistiocytosis experts
    • Hepatoblastoma
      Dr. Link is
      Experienced
      . Learn about Hepatoblastoma.
      See more Hepatoblastoma experts
    • Hereditary Neuroblastoma
      Dr. Link is
      Experienced
      . Learn about Hereditary Neuroblastoma.
      See more Hereditary Neuroblastoma experts
    • Langerhans Cell Histiocytosis
      Dr. Link is
      Experienced
      . Learn about Langerhans Cell Histiocytosis.
      See more Langerhans Cell Histiocytosis experts
    • Marginal Zone Lymphoma (MZL)
      Dr. Link is
      Experienced
      . Learn about Marginal Zone Lymphoma (MZL).
      See more Marginal Zone Lymphoma (MZL) experts
    View All 9 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    1. Homepage
    2. Pediatric Hematologist Oncologists Palo Alto, CA
    3. Dr. Michael P. Link
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved